ϵ

NYITCOM-Arkansas’ Rajagopalan Receives $573K NIH Grant for Cardiovascular Disease Research

News Staff| August 24, 2026

Viswanathan (Vishwa) Rajagopalan, Ph.D., an associate professor of biomedical and anatomical sciences at the College of Osteopathic Medicine at Arkansas State University (NYITCOM-Arkansas), has been awarded a $573,750 grant from the National Institutes of Health (NIH).

Vishwa Rajagopalan standing in front of a computer
Vishwa Rajagopalan

The funding[1] will further his research regarding the impact thyroid dysfunction has on cardiovascular disease (CVD), which is the leading cause of death in the United States.

The grant allows Rajagopalan to expand his cardiovascular research program at NYITCOM-Arkansas. His most recent grant will specifically look at how thyroid hormones affect heart health, focusing on the key role played by molecules called non-coding RNAs.

“Thyroid dysfunction is associated with an increased risk of cardiovascular disease and, in some patient populations, a higher rate of deaths,” Rajagopalan says. “The available treatment modalities alone can be insufficient to manage the complex cardiovascular disease. The intent of this project is to better understand the molecular mechanisms and biomechanics of what’s happening so we can find novel and safe RNA-based therapies and improve treatments for CVD.”

Medical students will also have the opportunity to work with him on this project. Robert “Drew” Fleming, Ph.D., an associate professor of mechanical engineering at A-State, will work alongside Rajagopalan as a significant contributor on the project. “Our research faculty continue to do outstanding work, and we’re delighted to once again see that recognized through significant federal funding,” says Shane Speights, D.O., site dean of NYITCOM-Arkansas. “Congratulations to Dr. Rajagopalan on yet another well-deserved award.” Earlier this year, Rajagopalan was named a Fellow of the American Heart Association in recognition of his work in cardiovascular research.

By Casey Pearce


[1] Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R15HL173850. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

More News

Hand holding vaccine syringe

A Flu Season Primer

A family medicine physician shares insight to help inform the university community about the flu and the importance of the flu vaccine.

Floral paths on campus

ϵ To Be Ranked Among National Universities

For the 2027 U.S. News & World Report annual rankings, ϵ will be included in a new ranking category—National Universities.

Group of faculty holding awards

Convocation 2026: Success in a Time of Change

At the annual faculty and staff convocation, ϵ President Jerry Balentine reflected on the accomplishments over the past year and presented his vision for the future.

Primates and humans walking and primate and human feet

The Evolutionary Significance of Humans’ Unique Heel-Toe Walking Pattern

Associate Professor of Anatomy Nathan E. Thompson, Ph.D., contributes to research unveiling clues to the origin of humans’ stride pattern.

Portraits of Zakir Hossain, Yihan Xu, and Christopher Janton

Robust Research

ϵ’s commitment to research paves the way for important and groundbreaking work. Meet three Ph.D. students whose work may improve disaster response, recovery after muscle and bone injuries, and anticancer therapies.

Group of people holding a large check standing in front of flags

NYITCOM-Arkansas Receives $1.5 Million Grant for Maternal Health Initiative

NYITCOM-Arkansas will use the grant to extend its clinical services focused on rural maternal healthcare access.